Atlanta Consulting Group Advisors LLC Sells 342 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atlanta Consulting Group Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,683 shares of the healthcare conglomerate’s stock after selling 342 shares during the period. Atlanta Consulting Group Advisors LLC’s holdings in UnitedHealth Group were worth $1,357,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. IMG Wealth Management Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at $177,000. GLOBALT Investments LLC GA boosted its position in UnitedHealth Group by 45.6% in the 4th quarter. GLOBALT Investments LLC GA now owns 18,793 shares of the healthcare conglomerate’s stock valued at $9,507,000 after buying an additional 5,890 shares during the last quarter. Signature Wealth Management Group boosted its position in UnitedHealth Group by 2.7% in the 4th quarter. Signature Wealth Management Group now owns 3,724 shares of the healthcare conglomerate’s stock valued at $1,884,000 after buying an additional 97 shares during the last quarter. SlateStone Wealth LLC boosted its position in UnitedHealth Group by 0.8% in the 4th quarter. SlateStone Wealth LLC now owns 10,583 shares of the healthcare conglomerate’s stock valued at $5,354,000 after buying an additional 86 shares during the last quarter. Finally, Nicholas Company Inc. boosted its position in shares of UnitedHealth Group by 2.2% in the 4th quarter. Nicholas Company Inc. now owns 142,641 shares of the healthcare conglomerate’s stock worth $72,156,000 after purchasing an additional 3,031 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $488.52 on Monday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $511.36 and a 200 day simple moving average of $549.80. The stock has a market capitalization of $446.85 billion, a PE ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the business earned $5.83 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on UNH shares. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Truist Financial dropped their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.